speb/financial-data huggingface dataset:
CVS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 515000000.00
CVS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 36706000000.00
CVS balance_sheet (quarterly, 2026-03-31) — Working Capital: -11589000000.00
CVS.DE balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
CVS.DE income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
CVS.DE income_statement (annual, 2021-12-31) — Other Special Charges: 452000000.00
CVS.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
CVS.DE cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CVS.DE income_statement (annual, 2022-12-31) — +Operating Expense: 38212000000.00
CVS.DE income_statement (annual, 2022-12-31) — +Total Revenue: 322467000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 14838000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 11659000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -21483000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 908000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 17562000000.00
CVS.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 1312000000.00
CVS.DE income_statement (annual, 2022-12-31) — Basic EPS: 3.29
CVS.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12691000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4545000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -2727000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 18478000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 48193000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 12945000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 15723000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2907000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -10516000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5047000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 16177000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Account Payable: 4260000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -1435000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -491000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 6463000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Payable: 5252000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5252000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Receivables: -2971000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: 6818000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2971000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Changes In Cash: 614000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Commercial Paper: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Common Stock: 48193000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2907000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 71469000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -3500000000.00
CVS.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 267965000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 18745000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Assets: 65633000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1678000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Debt: 1778000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3456000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 69421000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2029000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Deferred Tax: -2029000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 3228000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 4224000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 4224000000.00
CVS.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 1323000000.00
CVS.DE income_statement (annual, 2022-12-31) — Diluted EPS: 3.26
CVS.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 4311000000.00
CVS.DE income_statement (annual, 2022-12-31) — EBIT: 8123000000.00
CVS.DE income_statement (annual, 2022-12-31) — EBITDA: 12347000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Employee Benefits: 3228000000.00
CVS.DE cash_flow (annual, 2022-12-31) — End Cash Position: 13305000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10516000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 13450000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -475000000.00
CVS.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -2533000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1264000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Goodwill: 78150000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 102953000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 52228000000.00
CVS.DE income_statement (annual, 2022-12-31) — Gross Profit: 54502000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 989000000.00
CVS.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CVS.DE income_statement (annual, 2022-12-31) — Interest Expense: 2287000000.00
CVS.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2287000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -559000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Inventory: 19090000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 123723000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5047000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 18551000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Investments And Advances: 21096000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Land And Improvements: 1996000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Leases: 6238000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 16800000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 50476000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 67276000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CVS.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4211000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 21821000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 300000000.00
CVS.DE income_statement (annual, 2022-12-31) — Minority Interests: -16000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1388000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3500000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Net Debt: 39309000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income: 4311000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4311000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4327000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 4311000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4311000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4327000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4327000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Interest Income: -2287000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1017000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -4211000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -4211000000.00
CVS.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2287000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -449000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 85000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Net PPE: 30745000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2727000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -31484000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4016000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4016000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3228000000.00
CVS.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 20683000000.00
CVS.DE income_statement (annual, 2022-12-31) — Normalized Income: 10487976000.00
CVS.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 16177000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2058000000.00
CVS.DE income_statement (annual, 2022-12-31) — Operating Income: 16290000000.00
CVS.DE income_statement (annual, 2022-12-31) — Operating Revenue: 322467000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1300000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: 2636000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1778000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2817000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1264000000.00
CVS.DE income_statement (annual, 2022-12-31) — Other Income Expense: -8167000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 24803000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Inventories: 19649000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Investments: 2545000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 332000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4620000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 12565000000.00
CVS.DE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 169000000.00
CVS.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 38212000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Payable: 29565000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Properties: 17628000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 15617000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2778000000.00
CVS.DE income_statement (annual, 2022-12-31) — Other Special Charges: 5803000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Payables: 44403000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 63148000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CVS.DE income_statement (annual, 2022-12-31) — Pretax Income: 5836000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 551000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Properties: 0.00
CVS.DE cash_flow (annual, 2022-12-31) — Purchase Of Business: -1388000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7746000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2727000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Receivables: 27276000000.00
CVS.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 267965000000.00
CVS.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 4224000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4211000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3500000000.00
CVS.DE income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: 56398000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Sale Of Investment: 6729000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CVS.DE balance_sheet (annual, 2022-12-31) — Share Issued: 1758000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CVS.DE cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CVS.DE income_statement (annual, 2022-12-31) — Special Income Charges: -8336000000.00
CVS.DE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 447000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 71469000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: -31484000000.00
CVS.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2159024000.00
CVS.DE income_statement (annual, 2022-12-31) — Tax Provision: 1509000000.00
CVS.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CVS.DE balance_sheet (annual, 2022-12-31) — Total Assets: 228275000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 121945000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Debt: 70732000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 71769000000.00
CVS.DE income_statement (annual, 2022-12-31) — Total Expenses: 306177000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 156506000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 162642000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 87085000000.00
CVS.DE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 7954000000.00
CVS.DE income_statement (annual, 2022-12-31) — Total Unusual Items: -8336000000.00
CVS.DE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -8336000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 458000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Treasury Stock: 31858000000.00
CVS.DE balance_sheet (annual, 2022-12-31) — Working Capital: -3788000000.00
CVS.DE income_statement (annual, 2023-12-31) — +Operating Expense: 39832000000.00
CVS.DE income_statement (annual, 2023-12-31) — +Total Revenue: 357776000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 14897000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 15622000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -20699000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 152000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CVS.DE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 18582000000.00
CVS.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 1285000000.00
CVS.DE income_statement (annual, 2023-12-31) — Basic EPS: 6.49
CVS.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13305000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4571000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -3031000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 17775000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 48992000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 8196000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11455000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3132000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2683000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -20889000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 13426000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Account Payable: 3618000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Inventory: 1233000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -510000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1540000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Payable: 4012000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4012000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Receivables: -6260000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: 15000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -6260000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Changes In Cash: -4780000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Commercial Paper: 200000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Common Stock: 48992000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -3132000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 76461000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Common Stock Payments: -2012000000.00
CVS.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 303345000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 23515000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Assets: 67858000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1741000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Debt: 2972000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4713000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 79189000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Deferred Income Tax: -676000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Deferred Tax: -676000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 3250000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4366000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4366000000.00
CVS.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 1290000000.00
CVS.DE income_statement (annual, 2023-12-31) — Diluted EPS: 6.47
CVS.DE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 8344000000.00
CVS.DE income_statement (annual, 2023-12-31) — EBIT: 13831000000.00
CVS.DE income_statement (annual, 2023-12-31) — EBITDA: 18197000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Employee Benefits: 3250000000.00
CVS.DE cash_flow (annual, 2023-12-31) — End Cash Position: 8525000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2683000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Free Cash Flow: 10395000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -349000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -297000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Goodwill: 91272000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 120506000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Gross PPE: 51134000000.00
CVS.DE income_statement (annual, 2023-12-31) — Gross Profit: 54431000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 1183000000.00
CVS.DE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CVS.DE income_statement (annual, 2023-12-31) — Interest Expense: 2658000000.00
CVS.DE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2658000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -607000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Inventory: 18025000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Invested Capital: 138071000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -20889000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 19765000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Investments And Advances: 23019000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 16098000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Land And Improvements: 1958000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Leases: 6511000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 16034000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Long Term Debt: 58638000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 74672000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 10898000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3166000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 20842000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Minority Interest: 175000000.00
CVS.DE income_statement (annual, 2023-12-31) — Minority Interests: -24000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -16612000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2012000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Net Debt: 53414000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income: 8344000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 8344000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 8368000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 8344000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 8344000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 8368000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 8368000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Interest Income: -2658000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1314000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 7932000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 7732000000.00
CVS.DE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2658000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -382000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 68000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Net PPE: 30435000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3031000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 200000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -44045000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4311000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 4311000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3250000000.00
CVS.DE income_statement (annual, 2023-12-31) — Normalized EBITDA: 19053000000.00
CVS.DE income_statement (annual, 2023-12-31) — Normalized Income: 8985144000.00
CVS.DE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 13426000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 349000000.00
CVS.DE income_statement (annual, 2023-12-31) — Operating Income: 14599000000.00
CVS.DE income_statement (annual, 2023-12-31) — Operating Revenue: 357776000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1288000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Current Assets: 3151000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2772000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1141000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -297000000.00
CVS.DE income_statement (annual, 2023-12-31) — Other Income Expense: -768000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 29234000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Inventories: 18632000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Investments: 3254000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 264000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4660000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 11670000000.00
CVS.DE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 88000000.00
CVS.DE income_statement (annual, 2023-12-31) — Other Operating Expenses: 39832000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Payable: 34923000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Properties: 17252000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Receivables: 19605000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 3259000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Payables: 49820000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 73335000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CVS.DE income_statement (annual, 2023-12-31) — Pretax Income: 11173000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 277000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Properties: 0.00
CVS.DE cash_flow (annual, 2023-12-31) — Purchase Of Business: -16612000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -9043000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -3031000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Receivables: 35227000000.00
CVS.DE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 303345000000.00
CVS.DE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4366000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -8166000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2012000000.00
CVS.DE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 507000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Retained Earnings: 61604000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CVS.DE cash_flow (annual, 2023-12-31) — Sale Of Investment: 7729000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Share Issued: 1768000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 5200000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -5000000000.00
CVS.DE income_statement (annual, 2023-12-31) — Special Income Charges: -856000000.00
CVS.DE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 588000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 76461000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Tangible Book Value: -44045000000.00
CVS.DE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -214856000.00
CVS.DE income_statement (annual, 2023-12-31) — Tax Provision: 2805000000.00
CVS.DE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
CVS.DE balance_sheet (annual, 2023-12-31) — Total Assets: 249728000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Capitalization: 135099000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Debt: 79385000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 76636000000.00
CVS.DE income_statement (annual, 2023-12-31) — Total Expenses: 343177000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 173092000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 181870000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 93903000000.00
CVS.DE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 13743000000.00
CVS.DE income_statement (annual, 2023-12-31) — Total Unusual Items: -856000000.00
CVS.DE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -856000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 480000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Treasury Stock: 33838000000.00
CVS.DE balance_sheet (annual, 2023-12-31) — Working Capital: -11331000000.00
CVS.DE income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
CVS.DE cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 600000000.00
CVS.DE cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
CVS.DE income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 1169000000.00
CVS.DE cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 600000000.00
CVS.DE cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 200000000.00
CVS.DE income_statement (quarterly, 2024-09-30) — Special Income Charges: -1169000000.00
CVS.DE income_statement (quarterly, 2024-09-30) — Total Unusual Items: -1169000000.00
CVS.DE income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -1169000000.00
CVS.DE income_statement (annual, 2024-12-31) — +Operating Expense: 41706000000.00
CVS.DE income_statement (annual, 2024-12-31) — +Total Revenue: 372809000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Accounts Payable: 15892000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 14612000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -23447000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -23447000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 840000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
CVS.DE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 23777000000.00
CVS.DE income_statement (annual, 2024-12-31) — Basic Average Shares: 1259000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Basic Average Shares: 1259000000.00
CVS.DE income_statement (annual, 2024-12-31) — Basic EPS: 3.67
CVS.DE income_statement (quarterly, 2024-12-31) — Basic EPS: 1.31
CVS.DE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 8525000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4632000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4632000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Capital Expenditure: -2781000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 16650000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Capital Stock: 49661000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 8586000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 10993000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -3373000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1135000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -7613000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 9107000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Account Payable: 2335000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Inventory: -102000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -38000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3542000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Payable: 5092000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 5092000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Receivables: -1301000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Change In Working Capital: 109000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1301000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Changes In Cash: 359000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Commercial Paper: 2119000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Commercial Paper: 2119000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Common Stock: 49661000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -3373000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 75560000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Common Stock Payments: -3023000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Cost Of Revenue: 321408000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 20810000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Assets: 68645000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1751000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Debt: 5743000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7494000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Current Liabilities: 84609000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Deferred Income Tax: -572000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Deferred Tax: -572000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 3311000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Defined Pension Benefit: 3311000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4597000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 4597000000.00
CVS.DE income_statement (annual, 2024-12-31) — Diluted Average Shares: 1262000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 1261000000.00
CVS.DE income_statement (annual, 2024-12-31) — Diluted EPS: 3.66
CVS.DE income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.30
CVS.DE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4614000000.00
CVS.DE income_statement (annual, 2024-12-31) — EBIT: 9106000000.00
CVS.DE income_statement (annual, 2024-12-31) — EBITDA: 13703000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Employee Benefits: 3311000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 3311000000.00
CVS.DE cash_flow (annual, 2024-12-31) — End Cash Position: 8884000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1135000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Free Cash Flow: 6326000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CVS.DE income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CVS.DE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -120000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Goodwill: 91272000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 118595000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Gross PPE: 52384000000.00
CVS.DE income_statement (annual, 2024-12-31) — Gross Profit: 51401000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 1354000000.00
CVS.DE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Interest Expense: 2958000000.00
CVS.DE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2958000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Inventory: 18107000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Invested Capital: 141830000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -7613000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 25131000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Investments And Advances: 28934000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 9832000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 4273000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Land And Improvements: 1847000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1847000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Leases: 6725000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Leases: 6725000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 14899000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Long Term Debt: 60527000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 75426000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 7913000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 2954000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4773000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 23236000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 23236000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Minority Interest: 170000000.00
CVS.DE income_statement (annual, 2024-12-31) — Minority Interests: 28000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -95000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -3023000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CVS.DE balance_sheet (annual, 2024-12-31) — Net Debt: 57684000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income: 4614000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4614000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4586000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4614000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4614000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4586000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4586000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Interest Income: -2958000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -4838000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5059000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 3140000000.00
CVS.DE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2958000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -159000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 101000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Net PPE: 28937000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -2781000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 1919000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -43035000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3806000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3806000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3311000000.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3311000000.00
CVS.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 14391000000.00
CVS.DE income_statement (annual, 2024-12-31) — Normalized Income: 5127248000.00
CVS.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 9107000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -491000000.00
CVS.DE income_statement (annual, 2024-12-31) — Operating Income: 9695000000.00
CVS.DE income_statement (annual, 2024-12-31) — Operating Revenue: 372809000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1260000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: 3076000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 3624000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1183000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -120000000.00
CVS.DE income_statement (annual, 2024-12-31) — Other Income Expense: -589000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 27323000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Investments: 3803000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -502000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4793000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 10333000000.00
CVS.DE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 99000000.00
CVS.DE income_statement (annual, 2024-12-31) — Other Operating Expenses: 41706000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Payable: 39230000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Properties: 15944000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Receivables: 21857000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 2407000000.00
CVS.DE income_statement (annual, 2024-12-31) — Other Special Charges: -491000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Payables: 55122000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 75932000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Pretax Income: 6148000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 361000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Properties: 0.00
CVS.DE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CVS.DE cash_flow (annual, 2024-12-31) — Purchase Of Business: -95000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -15191000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2781000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Receivables: 36469000000.00
CVS.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 321408000000.00
CVS.DE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4597000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -4773000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3023000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1179000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 10000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 62837000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CVS.DE cash_flow (annual, 2024-12-31) — Sale Of Investment: 10353000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Share Issued: 1778000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 1919000000.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 1319000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
CVS.DE cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
CVS.DE income_statement (annual, 2024-12-31) — Special Income Charges: -688000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Special Income Charges: 381000000.00
CVS.DE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 540000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 75560000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: -43035000000.00
CVS.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -174752000.00
CVS.DE income_statement (annual, 2024-12-31) — Tax Provision: 1562000000.00
CVS.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
CVS.DE balance_sheet (annual, 2024-12-31) — Total Assets: 253215000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 136087000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Debt: 82920000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 75730000000.00
CVS.DE income_statement (annual, 2024-12-31) — Total Expenses: 363114000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 177485000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 184570000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 92876000000.00
CVS.DE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 8516000000.00
CVS.DE income_statement (annual, 2024-12-31) — Total Unusual Items: -688000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Total Unusual Items: 381000000.00
CVS.DE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -688000000.00
CVS.DE income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 381000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 518000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Treasury Stock: 36818000000.00
CVS.DE balance_sheet (annual, 2024-12-31) — Working Capital: -15964000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 11022000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 94588000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 16534000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 16660000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 23618000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1261000000.00
CVS.DE income_statement (quarterly, 2025-03-31) — Basic EPS: 1.41
CVS.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8884000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -743000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 16503000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 49837000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10076000000.00
CVS.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 12654000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -840000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -2332000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -762000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 4556000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2619000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Inventory: 722000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1101000000.00
CVS.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 1876000000.00